KalGene Inc Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

KalGene Inc General Information

Description

Developer of precision medicine therapeutics designed to slow the progression of Alzheimer's disease and cancer with an antibody-based approach. The company's therapeutics are aimed at improving clinical and survival efficacy through the use of personalized medicine to overcome safety issues, enabling physicians to alleviate patient suffering during treatment as well as improve the overall quality of life.

Contact Information

Website
www.kalgene.com
Formerly Known As
KalGene Pharmaceuticals, Kalgene Phamaceuticals Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6100 Royalmount Avenue
  • NRC Building
  • Montreal, Quebec H4P 2R2
  • Canada
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 6100 Royalmount Avenue
  • NRC Building
  • Montreal, Quebec H4P 2R2
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KalGene Inc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Dec-2025 Completed Product Development
8. Later Stage VC 20-Jan-2022 Completed Product Development
7. Secondary Transaction - Private 01-Jan-2020 Completed Product Development
6. Later Stage VC (Series A) 27-Nov-2017 Completed Product Development
5. Accelerator/Incubator Completed Startup
4. Accelerator/Incubator 11-May-2016 Completed Startup
3. Grant 05-Jun-2015 Completed Startup
2. Grant 23-Mar-2012 $130K Completed Startup
1. Accelerator/Incubator Completed Startup
To view KalGene Inc’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

KalGene Inc Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of precision medicine therapeutics designed to slow the progression of Alzheimer's disease and cancer with an
Drug Discovery
Montreal, Canada
2 As of 2022

Boston, MA
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KalGene Inc Competitors (62)

One of KalGene Inc’s 62 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CervoMed Formerly VC-backed Boston, MA
Centrose Venture Capital-Backed Madison, WI
Cerecin Venture Capital-Backed Broomfield, CO
Aptinyx Formerly VC-backed Evanston, IL
Hummingbird Bioscience Venture Capital-Backed Singapore, Singapore
You’re viewing 5 of 62 competitors. Get the full list »

KalGene Inc Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

KalGene Inc Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2012153186-A2 Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells Inactive 06-May-2011
WO-2012153186-A3 Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells Inactive 06-May-2011

KalGene Inc Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KalGene Inc Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chenel Capital Partners Asset Manager
K2X Venture Capital Minority
adMare Bioinnovations Corporation Minority
Brain Canada Government
Ontario Brain Institute Accelerator/Incubator Minority
To view KalGene Inc’s complete investors history, request access »

Ready to get started?

Request a free trial

KalGene Inc FAQs

  • When was KalGene Inc founded?

    KalGene Inc was founded in 2007.

  • Where is KalGene Inc headquartered?

    KalGene Inc is headquartered in Montreal, Canada.

  • What is the size of KalGene Inc?

    KalGene Inc has 2 total employees.

  • What industry is KalGene Inc in?

    KalGene Inc’s primary industry is Drug Discovery.

  • Is KalGene Inc a private or public company?

    KalGene Inc is a Private company.

  • What is KalGene Inc’s current revenue?

    The current revenue for KalGene Inc is .

  • How much funding has KalGene Inc raised over time?

    KalGene Inc has raised $5.94M.

  • Who are KalGene Inc’s investors?

    Chenel Capital Partners, K2X, adMare Bioinnovations, Brain Canada, and Ontario Brain Institute have invested in KalGene Inc.

  • Who are KalGene Inc’s competitors?

    CervoMed, Centrose, Cerecin, Aptinyx, and Hummingbird Bioscience are some of the 62 competitors of KalGene Inc.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process